PC

Prem Chand

Active Director Director DIN 08488404
DIN 08488404 First appointment Jun 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Prem Chand

Data last updated:

Prem Chand is a Director at Andomax Biotec Private Limited (since 2019). The company operates in Chemicals. Andomax Biotec Private Limited reported revenue of ₹89,112 (FY 2022).

DIN 08488404
Primary Designation Director
Industry Chemicals
First Appointment 20 Jun 2019
Oldest Company Age 7 yrs
Largest company Andomax Biotec Private Limited · ₹89,112 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Andomax Biotec Private Limited U24239UP2019PTC118265
Director20 Jun 20192019₹89,112 (FY 2022)Active

Board colleagues of Prem Chand

NameDINCompanyDesignation
Gyanchand08488405Andomax Biotec Private LimitedDirector

Directorship timeline

Open interactive timeline →
Andomax Biotec Private Limited
Premium access

Shareholding and investment profile for Prem Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prem Chand

Prem Chand currently holds 1 directorship: Andomax Biotec Private Limited (Director, since 20 Jun 2019, revenue ₹89,112 (FY 2022)).

Prem Chand was first appointed on 20 Jun 2019 as Director at Andomax Biotec Private Limited.

The current boards of Prem Chand's companies include Gyanchand (Andomax Biotec Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available